Increased risk of childhood leukaemia in the vicinity of highways
ISPM researchers found that young children living in the close vicinity (<100 m) of a highway have an increased risk of leukaemia.
Health risk assessment and counselling improves survival in older people
A study published this week in PLOS Medicine shows that a collaborative care model improves health behaviors and survival among community-dwelling older people.
More prizes for our PhD students!
In the last few weeks, four PhD students working at the ISPM Bern were awarded prizes for their abstracts at conferences or for their Master thesis. Congratulations!
ESTHER Switzerland Secretariat moves to ISPM
The Ensemble pour une Solidarité Thérapeutique Hospitalière En Réseau (ESTHER) was established by the French government in 2001 to address global inequalities in access to HIV drugs.
Dr. Georgia Salanti started this week her joint appointment with ISPM, BIHAM and CTU
Georgia arrived a few days ago from the University of Ioannina in Greece, were she is an Associate Professor in Biostatistics and Epidemiology.
Ebola vaccine tested successfully for the first time
A vaccine against the Ebola virus, tested in West Africa for the first time in a field trial, has proved to be effective according to the first interim analysis published today in The Lancet. ISPM researchers were involved in designing and implementing the World Health Organization (WHO) «Ebola ça Suffit» vaccine trial.
Joining forces: IEFM and ISPM merge
As of January 2016 the Institute for Evaluative Research in Medicine (IEFM) and the Institute of Social and Preventive Medicine (ISPM) will merge and continue to work under the name ISPM.
2014 impact factors are out
Here is the news about the numbers that are really not that important ;-). Click on the quicklink (Journal Citation Reports) for full details.
International Epidemiologic Databases to Evaluate AIDS - Southern Africa
The IeDEA-SA steering group meeting took place from 11 to 13 May 2015 in Victoria Falls, Zimbabwe.
Aerosolised measles vaccine did not work as well as subcutaneous vaccine in India
The results of a large randomised trial are published today in the New England Journal of Medicine. Nicola Low was an investigator on the trial, which was sponsored by WHO and the Serum Institute of India with funding from the Bill and Melinda Gates Foundation.
Background ionising radiation affects cancer risk in children
That ionising radiation increases cancer risks is well known from studies of people exposed to relatively high doses including atomic bomb survivors from Japan or patients receiving radiation therapy. But what about the more common low doses of radiation to which the population at large is exposed to such as natural background radiation or diagnostic radiology; do these also contribute to cancer risk and, if yes, do similar dose-response relationship apply?
GetReal Annual Meeting in Bern
The second GetReal General Assembly was hosted by the ISPM and University of Bern the 28-29 of January 2015.
Meeting of Young Researchers in Primary Ciliary Dyskinesia!
On March 12-13th, 2015 the ISPM Bern will host the first international young researchers meeting, with a focus on PCD. The conference, organized by young scientists from Bern, Southampton and Copenhagen, provides a unique opportunity for scientific exchange among doctoral students and junior researchers who work on PCD.
Ebola Vaccine Trial in Guinea
ISPM and CTU Bern will participate in a trial to evaluate the effectiveness of ring vaccination to control the current outbreak in Guinea, West Africa. We are urgently looking for staff to support this trial in Guinea and Bern.
Julia Bohlius and Kerri Clough-Gorr receive their Habilitation
We are delighted to announce the approval of the Habilitation of Jula Bohlius and Kerri Glough-Gorr by the Medical Faculty on 17 December 2014.
Olivia Keiser receives Theodor Kocher award 2014
Once a year, the University of Bern honours its best young researcher with the Theodor Kocher Prize. The prize, which is an award of CHF 50,000, is given to young researchers at the University of Bern for outstanding and innovative scientific achievement in any field.
Peter Jüni is the new professor of primary health care in Bern
ISPM Director, Prof. Dr. Peter Jüni, will be leaving to become the new chair of primary health care and director of the Bernese Institute of Primary Health Care (Berner Institut für Hausarztmedizin, BIHAM) on 1st December, 2014. Prof. Dr. Matthias Egger will resume the post of ISPM Director. We wish them both well.
Matthias Egger receives Achievement Award from the Netherlands Epidemiology Society.
Prof. Dr. Matthias Egger from the Institute of Social and Preventive Medicine received the Achievement Award 2014 by the Netherlands Epidemiology Society, for his important contributions in fields such as the development of methods in Epidemiology and treatment of HIV infection in southern Africa, as well as his outstanding teaching skills.
Accolades for our PhD students
Several PhD students won awards at recent conferences
Modern technologies for revascularisation superior to medical therapy in patients with stable coronary artery disease
Two related articles published today simultaneously in the New England Journal of Medicine and the Lancet.
Science features Ebola mathematical modelling predictions
“If the epidemic in Liberia were to continue in this way until the 1st of December, the cumulative number of cases would exceed 100,000,” says ISPM’s Christian Althaus.
What does your neighbourhood say about you? A lot - according to analysis of Swiss National Cohort
Although Switzerland has one of the highest life expectancies in the world ISPM researchers found that there are substantial geographical differences.
Epidemiology Winter School 2015 in Wengen - registration now open!
The Winter School takes place in January during the week following the International Lauberhorn ski race, when Wengen is calm, with few people on the slopes. Students stay on site and work hard in the mornings. They then have an extended break to review course materials, catch up on emails or (more likely) go skiing or snowboarding. We reconvene at 5 pm for computer or practical sessions.
RADAR-GO: Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea
RADAR-GO: Launch of an interdisciplinary project to develop a much needed test for antibiotic resistant Gonorrhoea.
SwissTransMed is funding the project RADAR-Go (Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea) to develop a rapid molecular test for antibiotic resistance and to predict its impact using mathematical modeling.
Breast cancer screening revisited
Commentaries published online in the New England Journal of Medicine and Annals of Internal Medicine suggest to think differently about breast cancer screening.
GetReal: launch of EU-funded project to get real life data into drug development
Once a new drug has been developed, it must be reviewed by both the regulators and health technology assessment (HTA) bodies. The regulators draw on data, mostly from clinical trials, to determine if a drug is safe and works well enough to be authorised for use in patients. For their part, HTA organisations assess the drug’s ‘relative effectiveness’, which is the extent to which a treatment does more good than harm when compared to one or more alternative treatments when provided under normal healthcare circumstances.
Women, the educated and those living alone more likely to choose assisted suicide
Today ISPM researchers publish a study online in the International Journal of Epidemiology that shows assisted suicide is more common in women, the divorced, those living alone, the more educated, those with no religious affiliation, and those from wealthier areas.
Preventing Mother-to-Child Transmission of HIV in Malawi
The HIV/AIDS and Hepatitis group has received a large grant from the Bill & Melinda Gates Foundation and an NIH Peer Grant.
The group will collaborate with the Malawi Ministry of Health to conduct a mixed-methods study to assess the effectiveness of Option B+, a simplified treatment protocol designed to prevent mother-to-child transmission of HIV.
Zweite, aktualisierte Auflage des Lehrbuchs „Public Health - Sozial- und Präventivmedizin kompakt“ erschienen!
Die von den Studierenden als sehr gut bewertete 1. Auflage des Lehrbuchs wurde vollständig aktualisiert und um Inhalte zu den Themen „Evidenzbasierte Medizin“, „Betriebliches Gesundheitsmanagement“ und „Herausforderungen einer alternden Gesellschaft“ ergänzt.
Magnus Unemo, expert in antimicrobial resistant gonorrhoea in Bern this week
Magnus will speak on “Gonorrhoea Management in the Era of Multidrug Resistance” on Tuesday 4th February 2014; 17:30-18:30; Room D517, Polikliniktrakt 2, Bern University Hospital (Eingang 29), 3010 Bern. As Director of the WHO Collaborating Centre for Gonorrhoea and other STIs, Örebro University Hospital, Sweden.
CIN3+plus: What impact on cervical cancer will HPV vaccination have?
Krebsforschung Schweiz is funding a research project from Feb 2014 to Jan 2016 to start monitoring the impact that vaccination against human papillomavirus (HPV) will have on cervical cancer and its precursors (grade 3 cervical intraepithelial neoplasia, CIN3). Nicola Low, ISPM Bern, leads the research with co-investigators from the Swiss Federal Office of Public Health, National Institute of Cancer Epidemiology and Research, Luzern Cantonal Hospital and Lausanne and Geneva University Hospitals.
5th Swiss Epidemiology Winterschool is in Wengen this week
Students can follow in the tracks of this year's Lauberhorn downhill champion, Swiss skier Patrick Küng, all week.
And here's the Wengen Slope report.
The website of the Swiss Epidemiology Winter School can be found here.